REGISTERED NUMBER: |
FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023 |
FOR |
SHS PHARMA LTD |
REGISTERED NUMBER: |
FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023 |
FOR |
SHS PHARMA LTD |
SHS PHARMA LTD (BY SHARES) (REGISTERED NUMBER: 09254015) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 MARCH 2023 |
Page |
Company Information | 1 |
Statement of Financial Position | 2 |
SHS PHARMA LTD (BY SHARES) |
COMPANY INFORMATION |
FOR THE YEAR ENDED 31 MARCH 2023 |
DIRECTOR: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: | STGCA LLP t/a Sterling |
Chartered Accountants |
505 Pinner Road |
Harrow |
Middlesex |
HA2 6EH |
SHS PHARMA LTD (BY SHARES) (REGISTERED NUMBER: 09254015) |
STATEMENT OF FINANCIAL POSITION |
31 MARCH 2023 |
31/3/23 | 31/3/22 |
£ | £ | £ | £ |
FIXED ASSETS |
CURRENT ASSETS |
CREDITORS |
Amounts falling due within one year | ( |
) | ( |
) |
NET CURRENT (LIABILITIES)/ASSETS | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
NOTES TO THE FINANCIAL STATEMENTS |
1. | AVERAGE NUMBER OF EMPLOYEES |
The average number of employees during the year was |
2. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES |
At the year ended 31 March 2023, £273,812 (2022 : £8,029) was due to the director of the company. Dividends amounting to £2,000 (2022 - £Nil) were paid to the director, during the year. |
The director acknowledges her responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the director and authorised for issue on |